ALB and liver disorder: There was a significant decrease in the amount of total HSA with the progression of liver disease (controls, 4.38 ± 0.27 g/dl; chronic hepatitis patients, 3.99 ± 0.37 g/dl; cirrhotic patients, 3.10 ± 0.55 g/dl) (Fig. 2a).